Leigh Serth

1
Aug

Dearric Winchester gets ready for 3 Day Cascade Lakes Relay to benefit migraine research

Over the course of a day, the average person will walk three miles. Over the course of three days, Dearric Winchester will run more than 72 times that average during the 11th annual Cascade Lakes Relay (CLR) in beautiful Central Oregon. Armed with months of training and a support van full of family and friends, Winchester will battle dramatic temperature

Read more

18
May

Use of Next Generation Sequencing Technology to identify novel hemiplegic migraine

Professor Lyn Griffiths Executive Director, Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia Conclusion: Dr. Griffiths has tested a quicker, more cost-effective genetic identification methodology, called Next Generation Sequencing(NGS). The utilization of the NGS methodology has proven successful in identifying individuals with the FHM mutation, and has proven to be 100% consistent with the older (Sanger) methodology. The

Read more

11
Mar

AMD’s upcoming events at Brain Week RI

Learn more about migraine disease and what to do about it.

7
Nov

AMD begins their podcast series “Shades of Migraine”

AMD begins their podcast series “Shades of Migraine”

28
Jul

Association of Migraine Disorders raises $14,000 for neuroscience research

The Association of Migraine Disorders raised $14,000 for research at its third annual Mad Hatter Party, held June 23 at the Squantum Association in East Providence. Read More

7
Jul

A Prospective Randomized Cross-over Trial of Nortiptyline and Topiramate

Full Project Title: A Prospective Randomized Cross-over Trial of Nortiptyline and Topiramatenin the initial Treatment of Vestibular Migraine Principal Investigator: Anthony Mikulec MD, MPH Professor, Chief, Otology and Nuerotology, Saint Louis University School of Medicine Update: Despite the high number of migraine patients in our clinics, it continues to be more challenging than anticipated to identify patients who have not previously

Read more

5
Nov

Taking Stock

As an ardent follower of the recent advances in the understanding and treatment of migraine disorders I am impressed with the great strides made over the last 24 months. It is remarkable that since the 1990s and the introduction of triptans, so much significant work in both prevention and treatment is now coming to fruition. So why now? What forces

Read more

27
Jun

Traumatic Brain Injuries and Migraines

Traumatic Brain Injury and Migraines: Civilian and Military Implications Consideration of this subject brings us to the intersection of some of the most critical issues challenging the migraine treatment community. With Memorial Day fading in the rear view mirror, we at AMD began to reflect on a number of these issues and thought looking at Traumatic Brain Injury (TBI) may

Read more

27
Jun

Migraine: Myth versus Reality

“There is no condition of such magnitude that is as shrouded in myth, misinformation, and mistreatment as is this condition [Migraine], and there are few conditions which are as disabling during the acute attack.” -Dr. Joel R. Saper, M.D., F.A.C.P., Director, Michigan Head-Pain & Neurological Institute A young science such as the one attempting to rid the world of migraine

Read more

27
Jun

Genetics: The Holy Grail of Migraine Research

In the end, it may be applied funding in genetics that discovers the cure or prevention that will end migraine disease. I would submit to you the “cure” or “grail” in the search for the ultimate root cause for this affliction may well be found in genetics. Our Excalibur is the science of genetics applied to migraine disease. With the

Read more

31
May

Dr. Godley Answers Five Questions in Providence Business News

1. What is a migraine, and how can you know you’re having one? A traditional migraine headache is an intense, throbbing pain that most people associate with the top of their heads. Those who suffer from migraines, also known as migraineurs, know a headache is coming on when they experience distortions of their vision or when their headache is accompanied by

Read more

25
May

2014 AAO-HNSF Conference

The American Academy of Otolaryngology-Head and Neck Surgery held its 2014 Conference in Orlando, FLA, last week and the Association of Migraine Disorders was an active participant on many levels. We manned a very busy booth for 3 days and interacted with literally hundreds of physicians, many of whom requested more information on AMD’s perspective on the spectrum of migraine

Read more

8
May

A Pharmaceutical Industry Update

This month, just prior to June Migraine Awareness Month, AMD is providing a comprehensive update on the FDA’s news and approvals of migraine medications. We think this is useful as it gives you a longitudinal look at the most current developments in migraine research including approvals, drugs in clinical trials, and recent industry news which could impact treatment options down

Read more

25
Apr

Migraine Caregiver Stress

How is it possible that such a devastating illness in all its expressions could not have far-reaching, negative effects in all relationship areas of a migraineurs life? It’s not, of course. Only recently have we begun to see research that looks at subjects like family burden and the disruption chronic migraine causes in the lives of sufferers. Very few of

Read more

26
Mar

Brown University Brain Fair

On March 19, 2016, The Association of Migraine Disorders participated in the Inaugural Brown “Brain Fair” held at Brown University at Sayles Hall. The turnout was excellent as scores of interested Fair-goers explored numerous interesting exhibits pertaining to brain science, many of which were interactive, and showcased the growing RI neuroscience community. The AMD exhibit garnered even more attention than

Read more

14
Mar

The Role of Metabotropic Glutamate Receptors in Migraine

Principal investigator: Maggie Waung, MD University of California, San Francisco Update: The main hypothesis of this project is that the metabotropic glutamate receptors are involved in trigeminovascular pain processing. This study is running under budget but, due to change in animal model, it has been extended for an additional year (2017).

27
Feb

A Migraine Relief Diet

Foreword for The Migraine Relief Diet is written by Frederick Godley, III, MD, FACS, President of the Association of Migraine Disorders and Michael Teixido, MD, Vice President of the Association of Migraine Disorders (excerpted from “The Migraine Relief Diet” by Tara Spencer, (c) Callisto Media/Althea Press), available here at Amazon.com in both softcover and kindle editions) Many people aren’t aware of how common

Read more

20
Feb

Headache on the Hill (HOH) 2016

This is an annual event, organized by the nonprofit Alliance for Headache Disorders Advocacy (AHDA), to advocate on behalf of Americans with disabling headache disorders. This is primarily a grassroots advocacy for increased funding of headache research. Its founder and thought-leader is Robert E. Shapiro, MD, PhD and its president is William B. Young, MD. AHDA is supported by a confederation

Read more

24
Oct

Annual AMD Scientific and Educational Board Meeting

Our first annual scientific and educational advisory board meeting, on October 23rd, was full of invigorating discussion and a wealth of great ideas. It underscores how essential the word “collaborate” is within the goals of our Mission. I am very grateful, for every member shared their time and expertise with a generosity of spirit in the common goal: assisting patients

Read more

20
Oct

AAO-HNSF OTO-Expo 2015

American Academy of Otolaryngology Head and Neck Surgery Foundation Dallas, Texas September 26-30, 2015 This is an international meeting of otolaryngologists with a choice of major guest lecturers, instructional courses, miniseminars, oral presentations, committee meetings, posters and a large expo.  15,000 participants. Relevance to AMD: opportunity to have a booth in the expo to distribute information about migraine disorders in

Read more

20
Oct

The 9th Annual Pain & Migraine Therapeutics Summit

Washington, DC    September 23-24, 2015 This is a two-day conference with presentations of the latest research and pharmaceutical findings regarding pain management and migraine disease. Participants: 80 and include representatives from CRO’s (Clinical Research Organizations), pharmaceutical companies and basic researchers – no clinicians Range of topics New animal and human study models New clinical measurements of pain New directions in

Read more